Tax

Tax Reconciliation, Foreign Rate Differential

Vertex Pharmaceuticals Tax Reconciliation, Foreign Rate Differential remained flat by 0.0% to $0.05 in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 3650.0%, from -$0.00 to $0.05.

Analysis

StatementIncome Statement
SectionTax
CategoryProfitability
SignalContext dependent
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2024Feb 13, 2026

How to read this metric

Changes in this value reflect shifts in the geographic mix of earnings or changes in foreign tax legislation.

Detailed definition

This represents the specific numerical adjustment in the tax reconciliation table that accounts for the variance between...

Peer comparison

Standard line item in the effective tax rate reconciliation note for global companies.

Metric ID: cop_tax_reconciliation_foreign_rate_differential

Historical Data

2 years
 FY'23FY'24
Value-$0.01$0.21
YoY Change>999%
Range-$0.01$0.21
Avg YoY Growth>999%
Median YoY Growth>999%

Frequently Asked Questions

What is Vertex Pharmaceuticals's tax reconciliation, foreign rate differential?
Vertex Pharmaceuticals (VRTX) reported tax reconciliation, foreign rate differential of $0.05 in Q4 2024.
How has Vertex Pharmaceuticals's tax reconciliation, foreign rate differential changed year-over-year?
Vertex Pharmaceuticals's tax reconciliation, foreign rate differential increased by 3650.0% year-over-year, from -$0.00 to $0.05.
What does tax reconciliation, foreign rate differential mean?
The specific tax reconciliation adjustment for foreign versus domestic tax rate differences.